BRIEF-Indian Immunologicals Clarifies On Abhayrab Vaccine, Counters Misplaced Advisory

Reuters2025-12-27

Dec 27 (Reuters) -

INDIAN IMMUNOLOGICALS - CLARIFIES ON ABHAYRAB VACCINE, COUNTERS MISPLACED ADVISORY
INDIAN IMMUNOLOGICALS - STRONGLY REFUTED THE OVER-CAUTIONARY AND MISPLACED REFERENCE TO 2023 MADE IN A RECENT AUSTRALIAN HEALTH ADVISORY
INDIAN IMMUNOLOGICALS - THE ADVISORY ON ABHAYRAB DOES NOT REFLECT THE CURRENT SITUATION
INDIAN IMMUNOLOGICALS - CO HAS ALREADY WRITTEN TO THE AUSTRALIAN HEALTH AUTHORITIES TO CONSIDER REVISING THE ABHAYRAB ADVISORY

Source text: [ID:]

Further company coverage: [ ]

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Amool
2025-12-27
Amool
What is this vaccine against

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2594724320?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-27 19:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2594724320","market":"us","top_or_hot":-1,"title":"BRIEF-Indian Immunologicals Clarifies On Abhayrab Vaccine, Counters Misplaced Advisory","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Indian Immunologicals Clarifies On Abhayrab Vaccine, Counters Misplaced Advisory</title></head><body><p><span>Dec 27 (Reuters)</span><span> - </span></p><ul><li><p>INDIAN IMMUNOLOGICALS - CLARIFIES ON ABHAYRAB VACCINE, COUNTERS MISPLACED ADVISORY</p></li><li><p>INDIAN IMMUNOLOGICALS - STRONGLY REFUTED THE OVER-CAUTIONARY AND MISPLACED REFERENCE TO 2023 MADE IN A RECENT AUSTRALIAN HEALTH ADVISORY</p></li><li><p>INDIAN IMMUNOLOGICALS - THE ADVISORY ON ABHAYRAB DOES NOT REFLECT THE CURRENT SITUATION</p></li><li><p>INDIAN IMMUNOLOGICALS - CO HAS ALREADY WRITTEN TO THE AUSTRALIAN HEALTH AUTHORITIES TO CONSIDER REVISING THE ABHAYRAB ADVISORY</p></li></ul><p>Source text: [ID:]</p><p>Further company coverage: [ ]</p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Indian Immunologicals Clarifies On Abhayrab Vaccine, Counters Misplaced Advisory</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Indian Immunologicals Clarifies On Abhayrab Vaccine, Counters Misplaced Advisory\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-27 19:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Indian Immunologicals Clarifies On Abhayrab Vaccine, Counters Misplaced Advisory</title></head><body><p><span>Dec 27 (Reuters)</span><span> - </span></p><ul><li><p>INDIAN IMMUNOLOGICALS - CLARIFIES ON ABHAYRAB VACCINE, COUNTERS MISPLACED ADVISORY</p></li><li><p>INDIAN IMMUNOLOGICALS - STRONGLY REFUTED THE OVER-CAUTIONARY AND MISPLACED REFERENCE TO 2023 MADE IN A RECENT AUSTRALIAN HEALTH ADVISORY</p></li><li><p>INDIAN IMMUNOLOGICALS - THE ADVISORY ON ABHAYRAB DOES NOT REFLECT THE CURRENT SITUATION</p></li><li><p>INDIAN IMMUNOLOGICALS - CO HAS ALREADY WRITTEN TO THE AUSTRALIAN HEALTH AUTHORITIES TO CONSIDER REVISING THE ABHAYRAB ADVISORY</p></li></ul><p>Source text: [ID:]</p><p>Further company coverage: [ ]</p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251227:nFWN3XW03Q:1","article_id":"2594724320","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2594724320","pubTimestamp":1766835254,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Indian Immunologicals Clarifies On Abhayrab Vaccine, Counters Misplaced AdvisoryDec 27  - INDIAN IMMUNOLOGICALS - CLARIFIES ON ABHAYRAB VACCINE, COUNTERS MISPLACED ADVISORYINDIAN IMMUNOLOGICALS - STRONGLY REFUTED THE OVER-CAUTIONARY AND MISPLACED REFERENCE TO 2023 MADE IN A RECENT AUSTRALIAN HEALTH ADVISORYINDIAN IMMUNOLOGICALS - THE ADVISORY ON ABHAYRAB DOES NOT REFLECT THE CURRENT SITUATIONINDIAN IMMUNOLOGICALS - CO HAS ALREADY WRITTEN TO THE AUSTRALIAN HEALTH AUTHORITIES TO CONSIDER REVISING THE ABHAYRAB ADVISORYSource text: [ID:]Further company coverage: [ ] ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"简报-印度免疫学澄清Abhayrab疫苗，反驳错误的建议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{},"content_text":"BRIEF-Indian Immunologicals Clarifies On Abhayrab Vaccine, Counters Misplaced AdvisoryDec 27 (Reuters) - INDIAN IMMUNOLOGICALS - CLARIFIES ON ABHAYRAB VACCINE, COUNTERS MISPLACED ADVISORYINDIAN IMMUNOLOGICALS - STRONGLY REFUTED THE OVER-CAUTIONARY AND MISPLACED REFERENCE TO 2023 MADE IN A RECENT AUSTRALIAN HEALTH ADVISORYINDIAN IMMUNOLOGICALS - THE ADVISORY ON ABHAYRAB DOES NOT REFLECT THE CURRENT SITUATIONINDIAN IMMUNOLOGICALS - CO HAS ALREADY WRITTEN TO THE AUSTRALIAN HEALTH AUTHORITIES TO CONSIDER REVISING THE ABHAYRAB ADVISORYSource text: [ID:]Further company coverage: [ ] ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[{"id":515367298650240,"gmtCreate":1766849661458,"gmtModify":1766849665535,"author":{"id":"4181616996179422","authorId":"4181616996179422","name":"Amool","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":12,"crmLevelSwitch":0,"idStr":"4181616996179422","authorIdStr":"4181616996179422"},"htmlText":"What is this vaccine against","listText":"What is this vaccine against","text":"What is this vaccine against","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/515367298650240","repostId":2594724320,"repostType":2,"repost":{"id":"2594724320","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"pubTimestamp":1766835254,"share":"https://ttm.financial/m/news/2594724320?lang=en_US&edition=fundamental","pubTime":"2025-12-27 19:34","market":"us","language":"en","title":"BRIEF-Indian Immunologicals Clarifies On Abhayrab Vaccine, Counters Misplaced Advisory","url":"https://stock-news.laohu8.com/highlight/detail?id=2594724320","media":"Reuters","summary":"BRIEF-Indian Immunologicals Clarifies On Abhayrab Vaccine, Counters Misplaced AdvisoryDec 27  - INDIAN IMMUNOLOGICALS - CLARIFIES ON ABHAYRAB VACCINE, COUNTERS MISPLACED ADVISORYINDIAN IMMUNOLOGICALS - STRONGLY REFUTED THE OVER-CAUTIONARY AND MISPLACED REFERENCE TO 2023 MADE IN A RECENT AUSTRALIAN HEALTH ADVISORYINDIAN IMMUNOLOGICALS - THE ADVISORY ON ABHAYRAB DOES NOT REFLECT THE CURRENT SITUATIONINDIAN IMMUNOLOGICALS - CO HAS ALREADY WRITTEN TO THE AUSTRALIAN HEALTH AUTHORITIES TO CONSIDER REVISING THE ABHAYRAB ADVISORYSource text: [ID:]Further company coverage: [ ] ","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Indian Immunologicals Clarifies On Abhayrab Vaccine, Counters Misplaced Advisory</title></head><body><p><span>Dec 27 (Reuters)</span><span> - </span></p><ul><li><p>INDIAN IMMUNOLOGICALS - CLARIFIES ON ABHAYRAB VACCINE, COUNTERS MISPLACED ADVISORY</p></li><li><p>INDIAN IMMUNOLOGICALS - STRONGLY REFUTED THE OVER-CAUTIONARY AND MISPLACED REFERENCE TO 2023 MADE IN A RECENT AUSTRALIAN HEALTH ADVISORY</p></li><li><p>INDIAN IMMUNOLOGICALS - THE ADVISORY ON ABHAYRAB DOES NOT REFLECT THE CURRENT SITUATION</p></li><li><p>INDIAN IMMUNOLOGICALS - CO HAS ALREADY WRITTEN TO THE AUSTRALIAN HEALTH AUTHORITIES TO CONSIDER REVISING THE ABHAYRAB ADVISORY</p></li></ul><p>Source text: [ID:]</p><p>Further company coverage: [ ]</p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Indian Immunologicals Clarifies On Abhayrab Vaccine, Counters Misplaced Advisory</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Indian Immunologicals Clarifies On Abhayrab Vaccine, Counters Misplaced Advisory\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-27 19:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Indian Immunologicals Clarifies On Abhayrab Vaccine, Counters Misplaced Advisory</title></head><body><p><span>Dec 27 (Reuters)</span><span> - </span></p><ul><li><p>INDIAN IMMUNOLOGICALS - CLARIFIES ON ABHAYRAB VACCINE, COUNTERS MISPLACED ADVISORY</p></li><li><p>INDIAN IMMUNOLOGICALS - STRONGLY REFUTED THE OVER-CAUTIONARY AND MISPLACED REFERENCE TO 2023 MADE IN A RECENT AUSTRALIAN HEALTH ADVISORY</p></li><li><p>INDIAN IMMUNOLOGICALS - THE ADVISORY ON ABHAYRAB DOES NOT REFLECT THE CURRENT SITUATION</p></li><li><p>INDIAN IMMUNOLOGICALS - CO HAS ALREADY WRITTEN TO THE AUSTRALIAN HEALTH AUTHORITIES TO CONSIDER REVISING THE ABHAYRAB ADVISORY</p></li></ul><p>Source text: [ID:]</p><p>Further company coverage: [ ]</p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251227:nFWN3XW03Q:1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2594724320","content_text":"BRIEF-Indian Immunologicals Clarifies On Abhayrab Vaccine, Counters Misplaced AdvisoryDec 27 (Reuters) - INDIAN IMMUNOLOGICALS - CLARIFIES ON ABHAYRAB VACCINE, COUNTERS MISPLACED ADVISORYINDIAN IMMUNOLOGICALS - STRONGLY REFUTED THE OVER-CAUTIONARY AND MISPLACED REFERENCE TO 2023 MADE IN A RECENT AUSTRALIAN HEALTH ADVISORYINDIAN IMMUNOLOGICALS - THE ADVISORY ON ABHAYRAB DOES NOT REFLECT THE CURRENT SITUATIONINDIAN IMMUNOLOGICALS - CO HAS ALREADY WRITTEN TO THE AUSTRALIAN HEALTH AUTHORITIES TO CONSIDER REVISING THE ABHAYRAB ADVISORYSource text: [ID:]Further company coverage: [ ] ((Reuters.Briefs@thomsonreuters.com;))","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":1,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2594724320","isCrawlerRequest":true}